Aveanna Healthcare (NASDAQ:AVAH) Downgraded by Zacks Research to Hold

Zacks Research lowered shares of Aveanna Healthcare (NASDAQ:AVAH) from a strong-buy rating to a hold rating in a research note published on Monday morning,Zacks.com reports.

Several other analysts also recently commented on AVAH. Jefferies Financial Group raised shares of Aveanna Healthcare from a “hold” rating to a “buy” rating and decreased their target price for the stock from $6.25 to $6.00 in a research report on Monday, July 21st. Raymond James Financial raised shares of Aveanna Healthcare from a “market perform” rating to an “outperform” rating and set a $9.00 target price for the company in a research report on Monday, August 11th. Weiss Ratings reissued a “hold (c)” rating on shares of Aveanna Healthcare in a research report on Wednesday, October 8th. UBS Group upped their price objective on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “neutral” rating in a report on Monday, October 13th. Finally, JPMorgan Chase & Co. raised shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and upped their price objective for the stock from $6.00 to $10.00 in a report on Thursday, September 18th. Three research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $8.08.

Aveanna Healthcare Stock Performance

Aveanna Healthcare stock opened at $10.23 on Monday. The firm has a market cap of $2.14 billion, a PE ratio of 127.88 and a beta of 2.05. Aveanna Healthcare has a twelve month low of $3.67 and a twelve month high of $10.32. The firm’s 50 day moving average price is $8.36 and its two-hundred day moving average price is $6.07.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. The company had revenue of $450.53 million during the quarter. Aveanna Healthcare had a net margin of 0.85% and a negative return on equity of 54.56%. Equities analysts anticipate that Aveanna Healthcare will post -0.06 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in AVAH. Banque Transatlantique SA bought a new position in shares of Aveanna Healthcare during the 1st quarter worth about $25,000. Quantbot Technologies LP acquired a new position in shares of Aveanna Healthcare in the 2nd quarter valued at $43,000. Diversified Trust Co acquired a new position in shares of Aveanna Healthcare in the 2nd quarter valued at $57,000. Jump Financial LLC acquired a new position in shares of Aveanna Healthcare in the 1st quarter valued at $59,000. Finally, MQS Management LLC acquired a new position in shares of Aveanna Healthcare in the 2nd quarter valued at $59,000. Institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.